Fiera Capital (Canada)
NVO

Fiera Capital (Canada)’s Novo Nordisk NVO Stock Holding History

Fiera Capital (Canada)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,134
Closed -$356K – 475
2024
Q4 		$356K Buy
4,134
+1,327
+47% +$144K ﹤0.01% 410
2024
Q3 		$334K Sell
2,807
-225
-7% -$30K ﹤0.01% 426
2024
Q2 		$433K Sell
3,032
-2,056
-40% -$272K ﹤0.01% 398
2024
Q1 		$653K Buy
5,088
+545
+12% +$64.9K ﹤0.01% 382
2023
Q4 		$470K Sell
4,543
-1,829
-29% -$181K ﹤0.01% 454
2023
Q3 		$579K Buy
6,372
+2,598
+69% +$229K ﹤0.01% 406
2023
Q2 		$305K Sell
3,774
-1,376
-27% -$112K ﹤0.01% 464
2023
Q1 		$410K Buy
5,150
+1,354
+36% +$96K ﹤0.01% 445
2022
Q4 		$257K Buy
+3,796
New +$223K ﹤0.01% 489
2018
Q3 		– Sell
-9,566
Closed -$221K – 714
2018
Q2 		$221K Hold
9,566
– – ﹤0.01% 639
2018
Q1 		$236K Sell
9,566
-158
-2% -$4.15K ﹤0.01% 606
2017
Q4 		$261K Sell
9,724
-512
-5% -$13K ﹤0.01% 576
2017
Q3 		$246K Buy
+10,236
New +$231K ﹤0.01% 583
2017
Q1 		– Sell
-297,842
Closed -$5.34M – 730
2016
Q4 		$5.34M Buy
297,842
+18,148
+6% +$329K 0.03% 306
2016
Q3 		$5.82M Buy
279,694
+204,214
+271% +$5.06M 0.03% 296
2016
Q2 		$2.03M Sell
75,480
-157,000
-68% -$4.31M 0.01% 479
2016
Q1 		$6.3M Sell
232,480
-5,000
-2% -$134K 0.05% 149
2015
Q4 		$6.9M Sell
237,480
-79,000
-25% -$2.19M 0.05% 161
2015
Q3 		$8.58M Buy
316,480
+3,482
+1% +$98.6K 0.07% 147
2015
Q2 		$8.57M Buy
312,998
+10,118
+3% +$284K 0.05% 157
2015
Q1 		$8.09M Buy
302,880
+50,000
+20% +$1.15M 0.06% 168
2014
Q4 		$5.35M Sell
252,880
-54,600
-18% -$1.22M 0.04% 194
2014
Q3 		$7.32M Buy
307,480
+19,000
+7% +$437K 0.05% 171
2014
Q2 		$6.66M Buy
288,480
+57,680
+25% +$1.27M 0.03% 197
2014
Q1 		$5.27M Sell
230,800
-22,600
-9% -$482K 0.04% 197
2013
Q4 		$936K Buy
+253,400
New +$4.42M 0.01% 417

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fiera Capital (Canada)'s NVO Position: Q1 2025 in Review

Fiera Capital (Canada) sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 4,134 shares — an estimated $356K sold.

Fiera Capital (Canada) first reported a position in NVO in Q4 2013 and held it in 26 quarters. The position peaked at $8.58M in Q3 2015. 1,533 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Fiera Capital (Canada) reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Fiera Capital (Canada) sold 4,134 Novo Nordisk shares in Q1 2025, an estimated $356K.
  • Fiera Capital (Canada) first reported a position in Novo Nordisk in Q4 2013 and held it in 26 quarters.
  • Fiera Capital (Canada)'s Novo Nordisk position peaked at $8.58M in Q3 2015.
  • 1,533 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Fiera Capital (Canada)'s 13F filing for Q1 2025, filed 7 May 2025.